Weight loss after breast cancer diagnosis may not improve prognosis

Journal of Clinical Oncology

Volumn 27, Issue 5, 2009, Pages 829-830

  Daniell, Harry W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

AXILLARY LYMPH NODE; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PREVENTION; DISEASE ASSOCIATION; HUMAN; LETTER; LYMPH NODE METASTASIS; MASTECTOMY; MENOPAUSE; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; TUMOR VOLUME; WEIGHT REDUCTION;

BREAST NEOPLASMS; FEMALE; HUMANS; OBESITY; PROGNOSIS; WEIGHT LOSS;

EID: 59949105535     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.5294     Document Type: Letter

References (11)

1. Litton J, Gonzales-Angulo A, Warneke C, et al: Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26:4072-4077, 2008
2. Griggs J, Sabel M: Obesity and cancer treatment: Weighing the evidence. J Clin Oncol 26:4060-4062, 2008
3. Hahn KM, Bondy ML, Selvan M, et al: Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol 166:103-144, 2007
4. Berclaz G, Li S, Price K, et al: Body mass index as a prognostic feature in operable breast cancer: The international breast cancer study group experience. Ann Oncol 15:875-884, 2004
5. Tao MH, Shu XO, Ruan ZX, et al: Association of overweight with breast cancer survival. Am J Epidemiol 163:101-107, 2006
6. Loi S, Milne R, Friedlander M, et al: Obesity and outcomes in premeno-pausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686-1691, 2005
7. Daling JR, Malone KE, Doody DR, et al: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720-729, 2001
8. Enger S, Ross R, Paganini-Hill A, et al: Body size, physical activity, and breast cancer hormone receptor status: Results from two case-control studies. Cancer Epidemiol Biomarkers Prev 9:681-687, 2000
9. Bastarrachea J, Hortobagyi G, Smith T, et al: Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 119:18-25, 1993
10. Dignam J, Wieand K, Johnson K, et al: Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467-1476, 2003
11. Daniell H, Tam E, Filice A: Larger axillary metastases in obese women and smokers with breast cancer: An influence by host factors on early tumor behavior. Breast Cancer Res Treat 25:193-201, 1993